Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 452,675 | 467,709 | 498,413 | 487,933 | 476,845 |
| Marketable Securities | 392,221 | 396,444 | 393,940 | 394,878 | 360,185 |
| Receivables | 81,068 | 73,977 | 75,880 | 69,761 | 63,094 |
| Inventories | 8,253 | 6,742 | 5,655 | 5,456 | 6,804 |
| TOTAL | $1,003,807 | $996,742 | $1,022,848 | $1,002,298 | $948,625 |
| Non-Current Assets | |||||
| PPE Net | 12,128 | 11,462 | 9,433 | 9,548 | 9,770 |
| Investments And Advances | 0 | 0 | 0 | 0 | 38,126 |
| Other Non-Current Assets | 56,160 | 59,065 | 70,219 | 70,541 | 31,487 |
| TOTAL | $68,288 | $70,527 | $79,652 | $80,089 | $79,383 |
| Total Assets | $1,072,095 | $1,067,269 | $1,102,500 | $1,082,387 | $1,028,008 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 30,157 | 24,364 | 22,956 | 23,856 | 29,105 |
| Accrued Expenses | 207,388 | 219,744 | 144,937 | 143,785 | 118,341 |
| TOTAL | $240,113 | $246,697 | $170,353 | $170,078 | $149,163 |
| Non-Current Liabilities | |||||
| Long Term Debt | 393,660 | 393,125 | 392,587 | 392,060 | 391,530 |
| Deferred Revenues | 572 | 583 | 582 | 594 | N/A |
| Other Non-Current Liabilities | 40,027 | 41,556 | 138,001 | 126,521 | 103,224 |
| TOTAL | $438,309 | $439,539 | $535,583 | $523,828 | $500,366 |
| Total Liabilities | $678,422 | $686,236 | $705,936 | $693,906 | $649,529 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,866 | 50,695 | 50,530 | 50,387 | 50,234 |
| Common Shares | 137 | 136 | 135 | 135 | 135 |
| Retained earnings | -818,304 | -831,275 | -801,215 | -801,038 | -790,738 |
| Other shareholders' equity | -35,372 | -28,083 | -30,005 | -26,613 | -33,089 |
| TOTAL | $393,673 | $381,033 | $396,564 | $388,481 | $378,479 |
| Total Liabilities And Equity | $1,072,095 | $1,067,269 | $1,102,500 | $1,082,387 | $1,028,008 |